Universal-Beteiligungs- und Servicegesellschaft
ALNY icon

Universal-Beteiligungs- und Servicegesellschaft’s Alnylam Pharmaceuticals ALNY Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.2M Buy
157,223
+17,515
+13% +$5.28M 0.07% 236
2026
Q1 		$46.1M Buy
139,708
+15,063
+12% +$5.13M 0.08% 231
2025
Q4 		$49.4M Buy
124,645
+14,093
+13% +$6.24M 0.08% 215
2025
Q3 		$50.4M Sell
110,552
-3,814
-3% -$1.55M 0.08% 206
2025
Q2 		$37.3M Sell
114,366
-3,354
-3% -$928K 0.07% 256
2025
Q1 		$31.8M Sell
117,720
-6,640
-5% -$1.71M 0.06% 274
2024
Q4 		$29.3M Buy
+124,360
New +$32.7M 0.06% 287

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's ALNY Position: Q2 2026 in Review

Universal-Beteiligungs- und Servicegesellschaft increased its Alnylam Pharmaceuticals (ALNY) stake by 13% in Q2 2026, buying an estimated $5.28M and bringing the position to 157,223 shares worth $47.2M. The position accounts for 0.07% of the portfolio, ranked #236.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in ALNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $50.4M in Q3 2025. 793 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Universal-Beteiligungs- und Servicegesellschaft held 157,223 shares of Alnylam Pharmaceuticals worth $47.2M as of Q2 2026.
  • Universal-Beteiligungs- und Servicegesellschaft bought 17,515 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $5.28M.
  • Alnylam Pharmaceuticals made up 0.07% of Universal-Beteiligungs- und Servicegesellschaft's portfolio in Q2 2026, its #236 holding.
  • Universal-Beteiligungs- und Servicegesellschaft first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Universal-Beteiligungs- und Servicegesellschaft's Alnylam Pharmaceuticals position peaked at $50.4M in Q3 2025.
  • 793 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q2 2026, filed 6 Aug 2026.